Eric Coldwell

Stock Analyst at Baird

(3.84)
# 712
Out of 5,042 analysts
188
Total ratings
60.58%
Success rate
6.03%
Average return

Stocks Rated by Eric Coldwell

Fortrea Holdings
Sep 3, 2025
Maintains: Outperform
Price Target: $9$14
Current: $11.30
Upside: +23.89%
ICON Public Limited Company
Sep 2, 2025
Maintains: Outperform
Price Target: $222$224
Current: $178.11
Upside: +25.76%
Quest Diagnostics
Aug 25, 2025
Downgrades: Neutral
Price Target: $194
Current: $182.18
Upside: +6.49%
Premier
Aug 20, 2025
Maintains: Neutral
Price Target: $22$27
Current: $28.12
Upside: -3.98%
Cardinal Health
Aug 13, 2025
Maintains: Outperform
Price Target: $197$203
Current: $161.89
Upside: +25.39%
Owens & Minor
Aug 12, 2025
Maintains: Outperform
Price Target: $10$7
Current: $5.51
Upside: +27.04%
Labcorp Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $290$302
Current: $279.49
Upside: +8.05%
Medpace Holdings
Jul 23, 2025
Maintains: Neutral
Price Target: $313$490
Current: $605.20
Upside: -19.04%
IQVIA Holdings
Jul 23, 2025
Maintains: Neutral
Price Target: $159$196
Current: $220.52
Upside: -11.12%
Charles River Laboratories International
May 8, 2025
Maintains: Neutral
Price Target: $118$140
Current: $197.04
Upside: -28.95%
Maintains: Outperform
Price Target: $14$16
Current: $9.37
Upside: +70.76%
Upgrades: Outperform
Price Target: $531$688
Current: $801.67
Upside: -14.18%
Maintains: Neutral
Price Target: $35$45
Current: $61.49
Upside: -26.82%
Maintains: Neutral
Price Target: $62$66
Current: $81.93
Upside: -19.44%
Maintains: Outperform
Price Target: $67$46
Current: $1.51
Upside: +2,946.36%